John M. Rossi
Université de Bordeaux(FR)Inserm(FR)Bordeaux Population Health(FR)BoRdeaux Institute of onCology(FR)
Publications by Year
Research Areas
CAR-T cell therapy research, Biosimilars and Bioanalytical Methods, Lymphoma Diagnosis and Treatment, Viral Infectious Diseases and Gene Expression in Insects, Immunotherapy and Immune Responses
Most-Cited Works
- → Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma(2017)5,738 cited
- → Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial(2018)2,184 cited
- → KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma(2020)1,759 cited
- → KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study(2021)736 cited
- → Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma(2017)606 cited
- → Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial(2021)589 cited